Contents
- 1 Quest Laboratories IPO Details
- 2 Quest Laboratories IPO Date
- 3 Quest Laboratories IPO Allotment Status
- 4 Know About Quest Laboratories Limited
- 5 Objects of the Issue IPO
- 6 Quest Laboratories Limited Promoters Holding
- 7 Quest Laboratories Limited Financial Report (Restated)
- 8 Key Performance Indicator (KPI) of Quest Laboratories Limited
- 9 Peer Group Comparison with Quest Laboratories Limited
- 10 Quest Laboratories Limited IPO Registrar
- 11 Quest Laboratories Limited IPO Book Running Lead Manager
- 12 Quest Laboratories Limited Contact
- 13 Broker Review
- 14 FAQs
Quest Laboratories Limited is gearing up for its initial public offering (IPO), aiming to raise Rs 43.16 crores through a fresh issue of 44,49,600 shares.
The Quest Laboratories IPO Date will open for subscription on May 15, 2024, and close on May 17, 2024. The company expects to finalize the allotment process by May 21, 2024, with plans to list on the NSE SME on May 23, 2024.
Investors can participate in the Quest Laboratories IPO within a price band of ₹93 to ₹97 per share. The minimum lot size for an application is 1200 shares, requiring a minimum investment of ₹116,400 for retail investors and ₹232,800 for High Net Worth Individuals (HNI), they need to apply for a minimum of 2 lots (2,400 shares).
Know About Quest Laboratories IPO GMP and Subscription to Click Here.
Refer to Quest Laboratories IPO RHP for more information.
Quest Laboratories IPO Details
Open Date | May 15, 2024 |
Close Date | May 17, 2024 |
Listing Date | May 23, 2024 |
IPO Size | 44.5 lakh equity shares aggregating up to ₹43.16 Cr. |
Fresh Issue | Aggregating up to ₹42.16 Cr with 44.5 lakh Share fresh Issue |
Face Value | ₹10 per share |
IPO Price Band | ₹93 to ₹97 |
IPO Listing on | NSE SME |
Lot Size | 1200 |
OFS | N.A |
Share Offered to Retail | Not Less Than 35% of the total issue share |
Share Offered to QBI | Not Less Than 50% of the total issue share |
Share Offered to HNI | Not Less Than 15% of the total issue share |
Quest Laboratories IPO Date
IPO Open Date | May 15, 2024 |
IPO Close Date | May 17, 2024 |
Basis of Allotment | May 21, 2024 |
Initiation of Refunds | May 22, 2024 |
The credit of Shares | May 22, 2024 |
Listing Date | May 23, 2024 |
Quest Laboratories IPO Allotment Status
You can check the allotment status for the Quest Laboratories IPO by following these steps. First, click the link BIGSHARE SERVICES PVT LTD Then, select the IPO Name from the options provided. After that, enter either your Application Number or PAN Number or Demat.
After entering the required information, click submit and view the allotment status of the IPO. This process should be done around the expected date of May 16, 2024.
Know About Quest Laboratories Limited
- Founded in June 1998, Quest Laboratories Limited is a pharmaceutical company. The company is best in the production of a diverse range of medications including antibiotics, antimalarials, antispasmodics, anti-inflammatories, and more.
- The company’s market presence extends across twelve states and two union territories in India, including Uttar Pradesh, Madhya Pradesh, Maharashtra, Delhi, and others.
- Quest Laboratories’ manufacturing facility is situated in Dhar, Madhya Pradesh.
- Holding prestigious certifications such as WHO Schedule M GMP, GLP, ISO/IEC 17025:2017, and ISO 9001:2015, the company maintains a high standard of quality and compliance.
- As of December 31st, 2023, Quest Laboratories employs 83 individuals responsible for various aspects of manufacturing operations, including production, quality control, technical support, inventory management, and administrative functions.
Objects of the Issue IPO
The company intends to allocate the Net Proceeds from the Issue towards the following objectives:
- Financing capital expenditure for acquiring plant and machinery to expand the existing manufacturing facility.
- Meet the working capital needs of the company.
- Catering to general corporate purposes.
Quest Laboratories Limited Promoters Holding
The company’s promoters are Mr. Anil Kumar Sabarwal and Ms. Tejaswini Sabarwal.
- Shareholding Pre-Issue: 90.36%
- Shareholding Post-Issue: 65.82%
Quest Laboratories Limited Financial Report (Restated)
Particulars | For the Period / Year ended on (₹ in Lakh) | |||
31st December, 2023 | 31st March, 2023 | 31st March, 2022 | 31st March, 2021 | |
Liabilities | 5,869.09 | 4,664.72 | 3,479.86 | 1,839.63 |
Assets | 5,869.09 | 4,664.72 | 3,479.86 | 1,839.63 |
Revenue | 6,217.83 | 6,186.60 | 5,954.20 | 3,043.55 |
PAT (Profit After Tax) | 774.93 | 502.85 | 410.50 | 65.50 |
Net Worth | 2,277.15 | 1,502.21 | 999.38 | 588.84 |
Key Performance Indicator (KPI) of Quest Laboratories Limited
As of December 31, 2023, Quest Laboratories Limited’s reported revenue of ₹6,217.83 lakhs, PAT of ₹774.93 lakhs, and a Net Worth of ₹2,277.15 lakhs. Key performance indicators include EBITDA of ₹1208.63 lakhs, RoCE of 41.86%, RoE of 34.03%, and RoNW of 34.03%.
Particulars | As of 31 December 2023 |
EBITDA | 1208.63 Lakh, 19.47% |
PAT Margin (in %) | 12.48% |
RoCE (%) | 41.86% |
RoE (%) | 34.03% |
RoNW (%) | 34.03% |
EPS | 4.21 in pre-issue and post-issue EPS is 6.31 |
PE Ratio | 23.03 Pre-issue and post-issue is 15.38 |
Peer Group Comparison with Quest Laboratories Limited
Company Name | CMP (₹) | Face Value (₹) | Basic & Diluted EPS (₹) | PE Ratio (times) | RoNW (%) | NAV per Share (₹) |
---|---|---|---|---|---|---|
Quest Laboratories Limited | [●] | 10 | 4.66 | [●] | 33.47% | 13.93 |
Peer Group Of Quest Laboratories Limited | ||||||
Beta Drugs Limited | 1300.00 | 10 | 19.57 | 66.43 | 19.55% | 100.12 |
Alpa Laboratories Limited | 93.95 | 10 | 5.90 | 15.92 | 8.59% | 68.69 |
Zenith Drugs Limited | 63.00 | 10 | 4.29 | 14.69 | 29.88% | 14.37 |
Quest Laboratories Limited IPO Registrar
BIGSHARE SERVICES PRIVATE LIMITED
Office No. S6-2, 6th Floor, Pinnacle Business Park,
Next to Ahura Centre, Mahakali CavesRoad, Andheri East,
Mumbai – 400 093, Maharashtra, India
Tel: 022 – 6263 8200
E-mail: ipo@bigshareonline.com
Investor grievance e-mail: investor@bigshareonline.com
Website: www.bigshareonline.com
Quest Laboratories Limited IPO Book Running Lead Manager
SHRENI SHARES LIMITED (Formerly Known as Shreni Shares Private Limited)
No. 217, Hive 67 Icon, Poisar Gymkhana Road,
Lokmanya Tilak Nagar Poisar, Near Raghuleela Mall,
Kandivali West, Mumbai – 400067, Maharashtra, India.
Telephone: 022 – 2089 7022
E-mail: shrenishares@gmail.com
Investors Grievance e-mail: info@shreni.in
Contact Person: Ms. Tanya Goyal
Website: www.shreni.in
Quest Laboratories Limited Contact
Quest Laboratories Limited
Plot No. 45, Sector III
Pithampur Industrial Area, Pithampur
Dhar – 454775,
Phone: 07292292374
Email: investors@questlabltd.com
Website: https://www.questlabltd.com/
Quest Laboratories IPO Application Form PDF
To download the Quest Laboratories IPO application form click on Application Form Download ASBA IPO Forms PDF.
Broker Review
Quest Laboratories shows strong financial reports on previous. So you may apply.
Disclaimer:
The information provided here, including company data and financial metrics, is for informational purposes only and does not constitute financial advice, investment recommendations, or solicitation to buy or sell securities. Investors should conduct thorough research or consult with financial professionals before making any investment decisions.
FAQs
When is the Quest Laboratories IPO opening for subscription?
The Quest Laboratories IPO will be open for subscription from May 15, 2024, to May 17, 2024.
What is the IPO size and price band?
The IPO size is 44.5 lakh equity shares aggregating up to ₹43.16 Cr, with a price band of ₹93 to ₹97 per share.
How can I check the allotment status of the IPO?
You can check the allotment status by visiting the website of BIGSHARE SERVICES PVT LTD and entering your Application Number or PAN Number or Demat.
2 thoughts on “Quest Laboratories IPO Date, Details, Allotment, Review”
Hi there, just became aware of your blog through Google, and found that it is truly informative.
I am going to watch out for brussels. I will appreciate if you continue this
in future. Numerous people will be benefited from your writing.
Thanks